(3R*,4R*)-3,4-EPOXY-4-(HYDROXYDIPHENYL)-METHYL-1-PHENYL-3-TRIFLUOROMETHYL-OCT-1-YNE
Compound with spectra: 1 NMR
| SpectraBase Compound ID | DEQXvghQgb |
|---|---|
| InChI | InChI=1S/C28H25F3O2/c1-2-3-20-25(26(33-25,28(29,30)31)21-19-22-13-7-4-8-14-22)27(32,23-15-9-5-10-16-23)24-17-11-6-12-18-24/h4-18,32H,2-3,20H2,1H3/t25-,26+/m1/s1 |
| InChIKey | YGHWRKCKPKJGBY-FTJBHMTQSA-N |
| Mol Weight | 450.5 g/mol |
| Molecular Formula | C28H25F3O2 |
| Exact Mass | 450.180665 g/mol |
| Enantiomer InChIKey | YGHWRKCKPKJGBY-IZZNHLLZSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
(3R*,4R*)-3,4-EPOXY-4-(HYDROXYDIPHENYL)-METHYL-1-PHENYL-3-TRIFLUOROMETHYL-OCT-1-ENE
(-)-8-alpha/8-beta -Hydroxy-1',1-dimethyl-delta9,11-tetrahydrocannabinol
6-(2-Chloro-ethyl)-4-ethyl-3-hydroxy-3',4',5'-trimethoxy-5-methyl-biphenyl-2-carboxylic acid ethyl ester
(R)-2-Phenyl-propionic acid 4-(7-hydroxy-3,5-diisopropyl-8,8-dimethyl-bicyclo[4.2.0]octa-1,3,5-trien-7-yl)-benzyl ester
(1S*,3R*,7S*,8R*)-9-Bromo-3-methoxy-10-methyl-4-oxatricyclo[5.3.1.0(3,8)]undec-9-en-2-one
1,4-Etheno-5,6,7-methenocyclopenta[c]pyran-3(1H)-one, 4,10-dichloro-4,4a,5,6,7,7a-hexahydro-
5-Methoxy-8-methyl-2,6-dioxo-2,6-dihydro-2H-pyrano-[3,2-g]chromene-3-carbonitrile
1(4H)-naphthalenone, 4-(1,1-dimethylethyl)-6-hydroxy-5-(2-pyridinyl)-
1,3,3,4,4-pentaphenyl-2-azetidinone
4-(2-Chloro-phenyl)-2-mercapto-5-oxo-1,4,5,6,7,8-hexahydro-quinoline-3-carbonitrile
| Title | Journal or Book | Year |
|---|---|---|
| New, General, and Stereoselective Synthesis of CF3-Containing Tri- and Tetrasubstituted Oxiranes and Tetrasubstituted Alkenes | Journal of the American Chemical Society | 2001 |
This compound is available in the following databases:
KnowItAll NMR Spectral Library
Author: Wiley
The KnowItAll NMR Spectral Library offers a comprehensive collection of NMR reference spectra, including NMR, CNMR, and XNMR, and covers a wide range of compounds including organics, polymers, monomers, metabolites, and more. Learn more.